The endogenous benzodiazepine receptor ligand ODN increases cytosolic calcium in cultured rat astrocytes

Brain Res Mol Brain Res. 1996 Apr;37(1-2):290-6. doi: 10.1016/0169-328x(95)00330-u.

Abstract

We have investigated the production of diazepam-binding inhibitor (DBI)-related peptides by astrocytes in primary culture and we have determined the effect of the octadecaneuropeptide DBI[33-50] (ODN) on the intracellular calcium concentration ([Ca2+]i) in astrocytes. Immunocytochemical labeling with antibodies against ODN showed that cultured astrocytes retain their ability to synthesize DBI in vitro. Cultured astrocytes were also found to release substantial amounts of ODN-immunoreactive material, and a brief exposure of astrocytes to a depolarizing potassium concentration resulted in a 5-fold increase in the rate of release of the ODN-like peptide. Microfluorimetric measurement of [Ca2+]i with the fluorescent probe indo-1 showed that nanomolar concentrations of ODN induced a marked increase in [Ca2+]i. The stimulatory effect of ODN on [Ca2+]i was not affected by calcium channel blockers or by incubation in Ca(2+)-free medium. In contrast, thapsigargin, an inhibitor of microsomal Ca(2+)-ATPase activity, totally abolished the ODN-induced increase in [Ca2+]i. Repeated pulses of ODN caused attenuation of the response, indicating the existence of a desensitization phenomenon. Preincubation of astrocytes with pertussis toxin totally blocked the effect of ODN on [Ca2+]i. The present study indicates that ODN-related peptides are synthesized and released by glial cells. Our results also show that synthetic ODN induces calcium mobilization from an intracellular store through stimulation of pertussis toxin-sensitive G protein. Taken together, these data suggest that endozepines act as paracrine and/or autocrine factors controlling the activity of astroglial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytes / drug effects*
  • Cadmium / pharmacology
  • Calcium / metabolism*
  • Diazepam Binding Inhibitor
  • Dose-Response Relationship, Drug
  • Immunohistochemistry
  • Neuropeptides / pharmacology*
  • Peptide Fragments
  • Rats
  • Rats, Wistar
  • Receptors, GABA-A / drug effects*

Substances

  • Diazepam Binding Inhibitor
  • Neuropeptides
  • Peptide Fragments
  • Receptors, GABA-A
  • diazepam binding inhibitor (33-50)
  • Cadmium
  • Calcium